FEIBA NF subst sèche 2500 U c solv flac

7680413520369 CH-41352 B02BD03 06.01.1.
FEIBA NF subst sèche 2500 U c solv flac
FEIBA NF subst sèche 2500 U c solv flac
1 / 2
google

Details

Product number
4135205
CPT
-
Packaging group
-
Unit
1 Durchstechflasche mit Pulver und 1 Durchstechflasche mit Lösungsmittel und Gerätesatz
Composition
Praeparatio cryodesiccata: F.E.I.B.A. 2500 U.I. ut proteinorum plasmatis humani solutio 1000-3000 mg, natrii citras dihydricus, natrii chloridum, natrii hydroxidum ad pH, pro vitro corresp. natrium 204.25 mg. Solvens: aqua ad iniectabile 50 ml pro vitro.

Articles (1)

Feiba NF 2500 E. (50 E/ml), Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Pulver
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
08/10/2024
Professional SmPC
Français
08/10/2024
Professional SmPC
Italien
08/10/2024

Detailed composition

Substance Quantity Type Category
aqua ad iniectabile
50.0 ML Substance HNIDK
F.E.I.B.A.
2500.0 UI Substance Wirkstoff (Principe actif)
proteinorum plasmatis humani solutio
- Substance WIZUS
natrii citras dihydricus
- Substance HNIDK
natrii chloridum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
natrium
204.25 MG Substance HBESI

Authorization holder

Takeda Pharma AG

8152 Opfikon

Authorization information

Swissmedic authorization number
41352
Drug name
Feiba NF, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Galenic form
PULMJ
ATC Code
B02BD03
Authorization status
Z
Dispensation category
B
First authorization
09/08/1979
Authorization expiration date
31/12/9999
IT number
06.01.1.
Domain
Human medicine
Field of application
Hemmkörperhämophilie mit Faktor VIII- bzw. Faktor IX-Inhibitor

Packaging details

Description (FR)
FEIBA NF subst sèche 2500 U c solv flac
Description (DE)
FEIBA NF Trockensub 2500 E c Solv Durchstf
Market launch
30/09/2010
Narcotic (BTM)
No

Other packaging sizes

FEIBA NF subst sèche 1000 U c solv flac
None LEER
View
Buy us a coffee Explore the data